Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4501 to 4515 of 7685 results

  1. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment for adults with chemotherapy-induced nausea and vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/6 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

    Research recommendation
    Published
    10 February 2020

  2. Chemoprevention to reduce incidence of breast cancer:- A randomised controlled trial is recommended to compare the clinical and cost effectiveness of aromatase inhibitors and tamoxifen for reducing the incidence of breast cancer in women with a family history of breast or ovarian cancer. [new 2013]

    Recommendation ID CG164/4 Question Chemoprevention to reduce incidence of breast cancer:- A randomised controlled trial is recommended

    Research recommendation
    Published
    9 June 2015

  3. What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment in babies, children and young people with chemotherapy-induced nausea or vomiting which persists with optimised conventional antiemetics?

    Recommendation ID NG144/7 Question What is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on treatment

    Research recommendation
    Published
    10 February 2020

  4. Children and young people aged 5 to 18 years – brief, group-based, ADHDfocused, parent-training intervention What is the clinical and cost effectiveness, and optimum length, of a brief parent-training intervention for parents and carers of children and young people with attention deficit hyperactivity disorder (ADHD) aged 5 to 18 years?

    Recommendation ID NG87/1 Question Children and young people aged 5 to 18 years – brief, group-based, ADHDfocused, parent-training intervention What

    Research recommendation
    Published
    14 November 2018

  5. Children and young people in transition between settings:- What is the effect of specific interventions to support children and young people during transition between inpatient mental health settings and community or care home settings? Is there any particular benefit for black, Asian and minority ethnic communities?

    Recommendation ID NG53/3 Question Children and young people in transition between settings:- What is the effect of specific interventions

    Research recommendation
    Published
    17 October 2016

  6. Chronic conditions:- What is the prevalence of disease in the UK prison population?

    Recommendation ID NG57/2 Question Chronic conditions:- What is the prevalence of disease in the UK prison population? Any explanatory

    Research recommendation
    Published
    16 November 2017

  7. For children and young people with intractable cancer-related pain and pain associated with specific diseases (such as epidermolysis bullosa), what is the clinical and cost effectiveness of cannabis-based medicinal products as an add-on to standard treatment to improve symptoms compared with treatment with standard care?

    Recommendation ID NG144/2 Question For children and young people with intractable cancer-related pain and pain associated with specific

    Research recommendation
    Published
    10 February 2020

  8. Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what is the overall effect on people's health?

    Recommendation ID NG70/3 Question Clean air zones:- How do different elements of a clean air zone interact to improve air quality and what

    Research recommendation
    Published
    12 October 2018

  9. Clinical predictors of non-IgE-mediated food allergy:- Which features in the clinical history best predict the presence of non-IgEmediated food allergy in children and young people in primary care and community settings?

    Recommendation ID CG116/2 Question Clinical predictors of non-IgE-mediated food allergy:- Which features in the clinical history best predict

    Research recommendation
    Published
    9 June 2015

  10. Antibiotics for suspected early-onset infection: What is the optimal antibiotic dosage regimen for the treatment of early-onset neonatal infection?

    Recommendation ID NG195/12 Question Antibiotics for suspected early-onset infection: What is the optimal antibiotic dosage regimen for

    Research recommendation
    Published
    6 August 2021

  11. What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women?

    Recommendation ID NG123/1 Question What is the effectiveness and safety of anticholinergic medicines for overactive bladder in older women

    Research recommendation
    Published
    21 June 2019

  12. Anticipatory prescribing:- What is the clinical and cost effectiveness of anticipatory prescribing for patients dying in their usual place of residence, on patient and carer reported symptoms at end of life?

    Recommendation ID NG31/4 Question Anticipatory prescribing:- What is the clinical and cost effectiveness of anticipatory prescribing for

    Research recommendation
    Published
    27 January 2016

  13. Should women having a surgical abortion up to and including 10 +0  weeks' gestation have anti-D prophylaxis if they are RhD (or D) negative?

    Recommendation ID NG140/3 Question Should women having a surgical abortion up to and including 10 +0 weeks' gestation have anti-D prophylaxis

    Research recommendation
    Published
    8 November 2019

  14. Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective treatment for idiopathic pulmonary fibrosis?

    Recommendation ID CG163/5 Question Anti-reflux therapy as a treatment for idiopathic pulmonary fibrosis:- Is anti-reflux therapy an effective

    Research recommendation
    Published
    9 June 2015

  15. Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically and cost effective in reducing surgical site infection rates?

    Recommendation ID NG125/4 Question Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically

    Research recommendation
    Published
    16 August 2019